Synergy appoints Troy Hamilton head of commercial
This article was originally published in Scrip
Executive Summary
Synergy Pharmaceuticals has named Troy Hamilton chief commercial officer. Mr Hamilton will be responsible for Synergy’s overall commercial strategy and execution, and will implement marketing, sales, and commercial operations and infrastructure for the US launch of plecanatide, Synergy's lead gastrointestinal (GI) product. Prior to joining Synergy, he held multiple commercial leadership roles over a nine year period within Shire Pharmaceuticals' GI business unit. Most recently, he was vice-president of product strategy and commercial lead responsible for the GI motility, hepatology and pipeline products.
You may also be interested in...
Finding Value Left On The Shelf: Karuna Case Study
PureTech’s gamble to take an older Eli Lilly drug off the shelf to redevelop in a new indication paid off. The company aims to replicate this 'Karuna model' in the near future.
Podcast: NodThera On The Role Of The Brain In Driving Chronic Disease
Alan Watt, CEO of NodThera, a clinical-stage biotech developing brain-penetrant NLRP3 inflammasome inhibitors to treat chronic inflammatory diseases, talks to In Vivo about the company’s pipeline and recent data publication in the field of obesity.
Deals Of The Year 2023 Winners Revealed
For In Vivo's 16th annual Deals of the Year contest, we selected 12 nominees in three categories – Top Alliance, Top Financing and Top M&A. The polls are closed, and it is time to reveal the winners.